When do firms change technology-sourcing vehicles? The role of poor innovative performance and financial slack

Abstract

This paper examines the adjustments firms make to the composition of their portfolios of technology‐sourcing vehicles (i.e., alliance, acquisition, or go‐it‐alone) in response to poor innovative performance. We advance a behavioral perspective on the make/buy/ally question, suggesting that differences in financial slack will generate different portfolio decisions. Specifically, we posit that firms with greater levels of financial slack are more likely to respond to poor innovative performance by opting for (1) greater vehicle diversification, and (2) new sourcing vehicles, while firms with less financial slack will respond by (1) downscoping their portfolio of sourcing vehicles, and (2) reverting to more familiar vehicles. We find support for our predictions using extensive data from the population of U.S. public pharmaceutical firms from 1992 to 2006. Copyright © 2015 John Wiley & Sons, Ltd.

Applications virtual special issue: Practical advice on how to unlock value from your alliances

“…However, an alliance is only one type of strategic vehicle a company can use to achieve such goals (Lungeanu, Stern, and Zajac, 2015). A number of recent studies suggest that a company's ability to extract value from its alliances depends on the other strategic vehicles that it is using (i.e.…”

“…An alliance is only one type of strategic vehicle a company can use to achieve goals such as accessing a new technology or penetrating a mew market (Lungeanu, Stern, and Zajac, 2015).…”

“…Alliances are formed for a variety of reasons, including entering new markets, developing new technologies, creating market power, minimizing transaction costs, increasing efficiencies, and accessing new or critical resources and capabilities. However, an alliance is only one type of strategic vehicle a company can use to achieve such goals (Lungeanu, Stern, and Zajac, 2015). A number of recent studies suggest that a company's ability to extract value from its alliances depends on the other strategic vehicles that it is using (i.e.…”

Relationship between international experience and innovation performance: The importance of organizational learning for EMNEs

“…This variable is a count of patents applied for by the focal firm that were approved by the USPTO in the given year. Patents are considered an output of R&D processes, and patents granted is a well‐established measure of innovation (Acs, Anselin, & Varga, ; Griliches, ; Lungeanu, Stern, & Zajac, ). Although one of the potential concerns with the use of patents as a measure of innovative activity by firms is that patents do not capture all new innovations, we believe that patents are fair indicators of innovation in the global biopharmaceutical industry, as well as the industry in India (Alvarez‐Garrido & Dushnitsky, ).…”

What Causes Technology Commercialization to Succeed or Fail after Transfer from Public Research Organizations

“…To have technology sourced and successfully commercialized, firms search for proper modes of technology transfer. This search ranges from traditional 'make, buy, or ally' decisions to narrower decisions such as licensing patented technologies, transfer of technology ownership, joint venture or a mix of those (Arora and Fosfuri, 2003;Lungeanu, Stern and Zajac, 2015;Somaya, Kim and Vonortas, 2011;Van de Vrande, 2013). For example, according to Somaya and his colleagues (2011), contractual licensing, especially exclusive licensing followed by patent scope restriction, offers a way to harness valuable technologies from other firms.…”